Celestica (CLS) is up 8.8% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely driver is a rebound in sentiment around Celestica’s AI infrastructure exposure after investors digested its large August equity raise. The company recently posted very strong second-quarter results, lifted its 2026 outlook again, and highlighted stronger customer demand and better visibility into 2027, which can support sharp upside moves after a pullback. This could also be because bullish analyst positioning in late August kept attention on the stock as the financing overhang began to fade.
Details:
Sources:
Celestica, SEC, Benzinga
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$CLS Insider Trading Activity
$CLS insiders have traded $CLS stock on the open market 141 times in the past 6 months. Of those trades, 0 have been purchases and 141 have been sales.
Here’s a breakdown of recent trading of $CLS stock by insiders over the last 6 months:
- ROBERT MIONIS (Chief Executive Officer) has made 0 purchases and 101 sales selling 322,553 shares for an estimated $122,167,849.
- MANDEEP CHAWLA (Chief Financial Officer) has made 0 purchases and 39 sales selling 34,000 shares for an estimated $13,070,061.
- MICHAEL MAX WILSON sold 4,168 shares for an estimated $1,389,236
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CLS Hedge Fund Activity
We have seen 516 institutional investors add shares of $CLS stock to their portfolio, and 445 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 3,874,584 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,413,448,243
- D. E. SHAW & CO., INC. added 1,782,300 shares (+1898.8%) to their portfolio in Q2 2026, for an estimated $650,183,040
- VIKING GLOBAL INVESTORS LP removed 1,654,989 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $603,739,987
- FMR LLC added 886,587 shares (+11.7%) to their portfolio in Q2 2026, for an estimated $323,426,937
- WINSLOW CAPITAL MANAGEMENT, LLC added 714,367 shares (+inf%) to their portfolio in Q2 2026, for an estimated $260,601,081
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 669,153 shares (-30.5%) from their portfolio in Q2 2026, for an estimated $244,107,014
- BLACKROCK, INC. removed 628,200 shares (-50.6%) from their portfolio in Q2 2026, for an estimated $229,167,360
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CLS Analyst Ratings
Wall Street analysts have issued reports on $CLS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Rothschild & Co issued a "Buy" rating on 05/01/2026
- JP Morgan issued a "Overweight" rating on 04/29/2026
To track analyst ratings and price targets for $CLS, check out Quiver Quantitative's $CLS forecast page.
$CLS Price Targets
Multiple analysts have issued price targets for $CLS recently. We have seen 11 analysts offer price targets for $CLS in the last 6 months, with a median target of $430.0.
Here are some recent targets:
- Mike Harrison from Rothschild & Co set a target price of $460.0 on 05/01/2026
- Tim Long from Barclays set a target price of $441.0 on 04/29/2026
- Mehdi Hosseini from Susquehanna set a target price of $510.0 on 04/29/2026
- Atif Malik from Citigroup set a target price of $415.0 on 04/29/2026
- John Shao from TD Cowen set a target price of $430.0 on 04/29/2026
- Paul Treiber from RBC Capital set a target price of $440.0 on 04/29/2026
- Samik Chatterjee from JP Morgan set a target price of $425.0 on 04/29/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.